SCHEMBL17248154

SCHEMBL17248154

COc1ccc(-c2nc(-c3ccc(OC)cc3)nc(-n3c4ccccc4c4ccc5c6ccccc6n(-c6ccccc6)c5c43)n2)cc1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A1 P04798 1/20 0.45
CYP1A2 P05177 1/20 0.45
CYP1B1 Q16678 1/20 0.45
ALDH1A1 P00352 5/20 0.44
SYK P43405 1/20 0.44
OXTR P30559 1/20 0.42
RAB9A P51151 2/20 0.42
NPSR1 Q6W5P4 2/20 0.42
SIRT1 Q96EB6 1/20 0.42
GLA P06280 1/20 0.41
ADORA3 P0DMS8 2/20 0.41
KDM4E B2RXH2 2/20 0.41
ATM Q13315 1/20 0.41
L3MBTL1 Q9Y468 1/20 0.41
MAPT P10636 3/20 0.40
ABCG2 Q9UNQ0 1/20 0.40
SMN1; SMN2 Q16637 3/20 0.39
MEN1 O00255 2/20 0.39
KMT2A Q03164 2/20 0.39
HTT P42858 2/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20051935 0.94 NPSR1 (0.48) CYP1A1CYP1A2CYP1B1ALDH1A1SYK
SCHEMBL17248169 0.90 CYP1A1 (0.41) CYP1A1CYP1A2CYP1B1ALDH1A1SYK
SCHEMBL12131866 0.89 CYP1A2 (0.41) CYP1A2ALDH1A1RAB9AKDM4EATM
SCHEMBL23600614 0.88 L3MBTL1 (0.49) ALDH1A1KDM4EATML3MBTL1MAPT
SCHEMBL12621179 0.88 ALDH1A1 (0.42) CYP1A1CYP1A2CYP1B1ALDH1A1SYK
SCHEMBL17636906 0.87 L3MBTL1 (0.47) ALDH1A1KDM4EATML3MBTL1MAPT
SCHEMBL12691038 0.87 L3MBTL1 (0.47) ALDH1A1KDM4EATML3MBTL1MAPT
SCHEMBL21365757 0.87 L3MBTL1 (0.47) ALDH1A1KDM4EATML3MBTL1MAPT
SCHEMBL24549670 0.87 L3MBTL1 (0.47) ALDH1A1KDM4EATML3MBTL1MAPT
SCHEMBL16521238 0.87 L3MBTL1 (0.47) ALDH1A1KDM4EATML3MBTL1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10361378-B2 Organic electroluminescent device NIPPON STEEL CHEMICAL & MATERIAL CO., LTD. (JP) 2019-07-23 US disclosed
EP-2933851-B1 ORGANIC ELECTROLUMINESCENT DEVICE NIPPON STEEL & SUMIKIN CHEM CO (JP) 2017-05-10 EP disclosed
US-20150325796-A1 ORGANIC ELECTROLUMINESCENT DEVICE NIPPON STEEL CHEMICAL & MATERIAL CO., LTD. (JP) 2015-11-12 US disclosed
US-20150325796-A1 ORGANIC ELECTROLUMINESCENT DEVICE NIPPON STEEL CHEMICAL & MATERIAL CO., LTD. (JP) 2015-11-12 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10361378-B2 Organic electroluminescent device ELF3, DDT, LEF1 CYP1A1 1561/4885CYP1A2 1211/4885CYP1B1 1953/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.